Clinical Outcome Of Hormonal Receptor Positive, Her-2 Negative Breast Cancer In Taiwan

Clinical trial NCT02924584 · COMPLETED

Trial details

NCT number: NCT02924584
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

ER/PR(+), Her2(-) Breast Cancer

Start date: 2017-02-01
Primary completion: 2017-02-28
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.